Beijing News (Reporter Zhang Xiulan) On March 11, the National Health and Medical Commission announced that following research, the State Council’s comprehensive team of the joint prevention and control mechanism for the new coronavirus pneumonia epidemic decided to add antigen testing as a supplement to nucleic acid testing. As soon as the news came out,straight flushAmong the 84 new crown testing concept stocks, 79 rose, The daily limit of 14 stocks including Lanwei Medical, Kefu Medical, Wanfu Bio, Aotai Bio, and Boto Bio.
According to the information on the official website of the State Food and Drug Administration, as of the beginning of January this year, a total of 69 new coronavirus detection products have been approved in China. method, approved in November 2021), Beijing Jinwofu Bioengineering Technology Co., Ltd. novel coronavirus (2019-nCov) antigen detection kit (latex method, approved in November 2021), Guangzhou Wanfu Biotechnology Co., Ltd. The company’s new coronavirus (2019-nCov) antigen detection kits (colloidal gold method, approved in November 2021) have been approved for 3 antigen detection products, all of which are used for oropharyngeal swabs, nasopharyngeal swabs, and nasopharyngeal Novel coronavirus N antigen detection in swab samples is generally used in the acute infection period, that is, the detection of samples within 7 days of the onset of symptoms of suspected people, and cannot be used alone for the diagnosis of new coronavirus infection. Product application/intended use indicates that it should be used by professionally trained personnel in an environment that ensures biosafety and meets the conditions of use. The staff of BGI Yinyuan also told the Beijing News reporter that the above-mentioned testing products are recommended to be used in medical institutions.
In addition, the new coronavirus antigen self-test kits of ten companies including Oriental Bio, Shengxiang Bio, Rejing Bio, Wanfu Bio, Jidan Bio, Botuo Bio, Daan Gene, Yahuilong, and Dean Diagnostics have been launched in Approved abroad. Among them, Wanfu Bio stated on the investor interaction platform in November 2021 that the new coronavirus antigen self-test kit developed by it will be sold in Europe, Asia, Latin America and other countries and regions. In the first three quarters of the year, the revenue of the new crown business was regarding 800 million yuan, most of which came from overseas markets. Daan Gene stated in December 2021 that the novel coronavirus antigen detection kit (colloidal gold method) and novel coronavirus (SARS-Cov-2) IgM-IgG used by its wholly-owned subsidiary Zhongshan Bioengineering Co., Ltd. for self-testing Antibody detection kits (colloidal gold immunochromatography) have been exported overseas. In January this year, Yahuilong also issued an announcement that the novel coronavirus (SARS-Cov-2) antigen detection kit (colloidal gold immunochromatography) independently developed and produced by the company has obtained the EU CE certificate.
Proofreading Lucy Return to Sohu, see more
Editor:
Disclaimer: The opinions of this article only represent the author himself, Sohu is an information publishing platform, and Sohu only provides information storage space services.
